Pappas Capital invests exclusively in the life science sector. For 27 years we have been investing in and building innovative companies that are developing the next generation of life science products and technologies. We’ve invested in more than 85 companies across the United States and Canada, in fields that span the range of human disease. The 22 products our companies have brought to market – for treating such conditions as melanoma, ovarian cancer, and hemophilia, to name a few – have been used throughout the world to treat tens of thousands of patients and account for billions of dollars of revenue.
Whether you’re looking for capital or have capital to invest, contact us and learn how we can put our expertise to work for you.
Location: United States, North Carolina, Durham
Employees: 11-50
Founded date: 1994
Investment Type: Venture Capital
Portfolio 1
Date | Name | Website | Total Raised | Location |
31.03.2023 | Horizon Qu... | horizonqua... | $21.33M | Singapore |
Mentions in press and media 17
Date | Title | Description | Source |
06.12.2021 | Better.com’s morale and SPAC merger success in question afte... | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
06.12.2021 | Better.com’s morale and SPAC merger success in question afte... | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
05.11.2020 | Pappas Capital Portfolio Company VelosBio to be Acquired by ... | RESEARCH TRIANGLE PARK, N.C., Nov. 5, 2020 /PRNewswire/ -- Pappas Capital, a leading venture capit... | prnewswire... |
05.11.2020 | MERCK & CO., INC. Pappas Capital : Portfolio Company Ve... | RESEARCH TRIANGLE PARK, N.C., Nov. 5, 2020 /PRNewswire/ -- Pappas Capital, a leading venture capital... | marketscre... |
05.11.2020 | Merck paying $2.75B for cancer therapeutics firm VelosBio | Promoted Covid-19’s terrible toll on diabetes patients. What can be done? The public health crisis... | medcitynew... |
11.05.2020 | Pappas Capital : Portfolio Company VelosBio to be Acquired b... | RESEARCH TRIANGLE PARK, N.C., Nov. 5, 2020 /PRNewswire/ -- Pappas Capital, a leading venture capital... | marketscre... |
11.09.2019 | Pappas Ventures Appoints Alex Arfaei as Partner | Pappas Capital, a leading investor in early-stage life sciences companies, announced today that Alex... | citybizlis... |
11.04.2018 | Term Sheet — Wednesday, April 11 | CRYPTO CAPITAL HOUSEKEEPING: I’ll be on vacation until April 20, so my wonderful colleague Lucinda ... | fortune.co... |
04.01.2018 | Term Sheet — Thursday, January 4 | TAKING A HIATUS Good morning, Term Sheet readers. Paid Content You can't secure what you can't see... | fortune.co... |
03.01.2018 | Pappas Capital Names Dr. Kyle Rashbach as a Partner | Pappas Capital announced today that Kyle Rasbach, PhD, PharmD has joined the firm as a partner. Dr. ... | citybizlis... |
Show more